
Alert – FDA –
This page lists warning letters FDA has issued to firms marketing cannabis-derived products, including cannabidiol (CBD) and delta-8 tetrahydrocannabinol (delta-8 THC) products.
FDA will continue to take action against CBD and other cannabis-derived products to protect the public, in coordination with state regulatory partners, when appropriate. We will remain diligent in monitoring the marketplace and acting within our authorities.
Leave a Reply